WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for KYMR

Based on 9 analysts offering 12 month price targets for Kymera Therapeutics Inc.
Min Forecast
$24.00-31.84%
Avg Forecast
$41.67+18.34%
Max Forecast
$56.00+59.05%

Should I buy or sell KYMR stock?

Based on 9 analysts offering ratings for Kymera Therapeutics Inc.
Buy
Strong Buy
4 analysts 44.44%
Buy
2 analysts 22.22%
Hold
3 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KYMR stock forecasts and price targets.

KYMR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-22
lockedlocked$00.00+00.00%2024-03-01Find Out Why
lockedlocked$00.00+00.00%2024-02-27
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2024-02-23
Bank of America
Bottom 7%
7
HoldDowngrades$30.00-14.80%2024-01-03
Wells Fargo
Top 2%
99
HoldDowngrades$26.00-26.16%2023-12-19
Morgan Stanley
Top 33%
68
HoldMaintains$24.00-31.84%2023-11-13
HC Wainwright & Co.
Top 4%
97
BuyMaintains$30.00-14.80%2023-11-03

1 of 1

Forecast return on equity

Is KYMR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is KYMR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

KYMR revenue forecast

What is KYMR's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$55.8M-29.05%
Avg 2 year Forecast
$70.8M-9.92%
Avg 3 year Forecast
$72.0M-8.41%
KYMR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KYMR revenue growth forecast

How is KYMR forecast to perform vs Biotechnology companies and vs the US market?
Company
-1.66%
Industry
37.5%
Market
10.08%
KYMR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KYMR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KYMR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KYMR$35.21$41.67+18.34%Buy
TGTX$13.98$30.20+116.02%Strong Buy
RCKT$23.63$54.33+129.93%Strong Buy
DNLI$15.56$44.67+187.06%Strong Buy
VERA$39.95$32.29-19.18%Strong Buy
View Top Biotech Stocks

Kymera Therapeutics Stock Forecast FAQ

Is Kymera Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: KYMR) stock is to Buy KYMR stock.

Out of 9 analysts, 4 (44.44%) are recommending KYMR as a Strong Buy, 2 (22.22%) are recommending KYMR as a Buy, 3 (33.33%) are recommending KYMR as a Hold, 0 (0%) are recommending KYMR as a Sell, and 0 (0%) are recommending KYMR as a Strong Sell.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.

What is KYMR's revenue growth forecast for 2024-2026?

(NASDAQ: KYMR) Kymera Therapeutics's forecast annual revenue growth rate of -1.66% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Kymera Therapeutics's revenue in 2024 is $78,592,000.On average, 10 Wall Street analysts forecast KYMR's revenue for 2024 to be $3,407,709,389, with the lowest KYMR revenue forecast at $928,897,506, and the highest KYMR revenue forecast at $7,638,959,750. On average, 10 Wall Street analysts forecast KYMR's revenue for 2025 to be $4,326,279,021, with the lowest KYMR revenue forecast at $2,138,908,730, and the highest KYMR revenue forecast at $7,889,517,630.

In 2026, KYMR is forecast to generate $4,398,818,582 in revenue, with the lowest revenue forecast at $916,675,170 and the highest revenue forecast at $9,166,751,700.

What is KYMR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KYMR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is KYMR's Price Target?

According to 9 Wall Street analysts that have issued a 1 year KYMR price target, the average KYMR price target is $41.67, with the highest KYMR stock price forecast at $56.00 and the lowest KYMR stock price forecast at $24.00.

On average, Wall Street analysts predict that Kymera Therapeutics's share price could reach $41.67 by Apr 22, 2025. The average Kymera Therapeutics stock price prediction forecasts a potential upside of 18.34% from the current KYMR share price of $35.21.

What is KYMR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KYMR) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.